M. Ángeles Villaronga

Impact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas

Darío García‐Carracedo, M. Ángeles Villaronga, Saúl Álvarez–Teijeiro et al. · Oncotarget · 2016 · 77 citations · Full text

Medicine, Cancer Biology, Oncology +17

Factors Secreted by Cancer-Associated Fibroblasts that Sustain Cancer Stem Properties in Head and Neck Squamous Carcinoma Cells as Potential Therapeutic Targets

Saúl Álvarez–Teijeiro, Cristina García–Inclán, M. Ángeles Villaronga et al. · Cancers · 2018 · 60 citations · Full text

Medicine, Cancer Biology, Oncology +17

Repression of Androgen Receptor Activity by HEYL, a Third Member of the Hairy/Enhancer-of-split-related Family of Notch Effectors

Derek N. Lavery, M. Ángeles Villaronga, Marjorie M. Walker et al. · Journal of Biological Chemistry · 2011 · 54 citations · Full text

Life Sciences, Endocrinology, Molecular Biology +17

Frequent aberrant expression of the human ether à go-go (hEAG1) potassium channel in head and neck cancer: pathobiological mechanisms and clinical implications

Sofía T. Menéndez, M. Ángeles Villaronga, Juan P. Rodrigo et al. · Journal of Molecular Medicine · 2012 · 42 citations · Full text

Medicine, Cancer Biology, Oncology +16

A Novel Role For Nanog As An Early Cancer Risk Marker In Patients With Laryngeal Precancerous Lesions

Juan P. Rodrigo, M. Ángeles Villaronga, Sofía T. Menéndez et al. · Scientific Reports · 2017 · 42 citations · Full text

Medicine, Cancer Biology, Oncology +15